177 related articles for article (PubMed ID: 38765596)
1. The Vitamin D Metabolite Diagnostic Ratio Associates With Phenotypic Traits of Idiopathic Hypercalciuria.
Dhayat NA; Mattmann C; Seeger H; Ritter A; Ernandez T; Stoermann-Chopard C; Buchkremer F; Segerer S; Roth B; Wuerzner G; Wagner CA; Bonny O; Popp AW; Vogt B; Bargagli M; Fuster DG
Kidney Int Rep; 2024 Apr; 9(4):1072-1082. PubMed ID: 38765596
[TBL] [Abstract][Full Text] [Related]
2. Expression of vitamin D receptor, CYP27B1 and CYP24A1 hydroxylases and 1,25-dihydroxyvitamin D
Melo TL; Esper PLG; Zambrano LI; Ormanji MS; Rodrigues FG; Heilberg IP
Urolithiasis; 2020 Feb; 48(1):19-26. PubMed ID: 31696245
[TBL] [Abstract][Full Text] [Related]
3. Vitamin D deficiency is prevalent among idiopathic stone formers, but does correction pose any risk?
Johri N; Jaeger P; Ferraro PM; Shavit L; Nair D; Robertson WG; Gambaro G; Unwin RJ
Urolithiasis; 2017 Dec; 45(6):535-543. PubMed ID: 27981376
[TBL] [Abstract][Full Text] [Related]
4. Loss-of-function mutations of CYP24A1, the vitamin D 24-hydroxylase gene, cause long-standing hypercalciuric nephrolithiasis and nephrocalcinosis.
Dinour D; Beckerman P; Ganon L; Tordjman K; Eisenstein Z; Holtzman EJ
J Urol; 2013 Aug; 190(2):552-7. PubMed ID: 23470222
[TBL] [Abstract][Full Text] [Related]
5. Predictors of Bone Mineral Density in Kidney Stone Formers.
Dhayat NA; Schneider L; Popp AW; Lüthi D; Mattmann C; Vogt B; Fuster DG
Kidney Int Rep; 2022 Mar; 7(3):558-567. PubMed ID: 35257068
[TBL] [Abstract][Full Text] [Related]
6. CYP24A1 loss of function: Clinical phenotype of monoallelic and biallelic mutations.
Carpenter TO
J Steroid Biochem Mol Biol; 2017 Oct; 173():337-340. PubMed ID: 28093352
[TBL] [Abstract][Full Text] [Related]
7. [Alterations in bone mineral metabolism in patients with calcium kidney stone disease and polymorphism of vitamin D receptor. Preliminary results].
Moyano MJ; Gómez de Tejada MJ; García Lozano R; Moruno R; Ortega R; Martí V; Sánchez Palencia R; Miranda MJ; Palma A; Pérez Cano R
Nefrologia; 2007; 27(6):694-703. PubMed ID: 18336098
[TBL] [Abstract][Full Text] [Related]
8. Dietary interventions for preventing complications in idiopathic hypercalciuria.
Escribano J; Balaguer A; Roqué i Figuls M; Feliu A; Ferre N
Cochrane Database Syst Rev; 2014 Feb; 2014(2):CD006022. PubMed ID: 24519664
[TBL] [Abstract][Full Text] [Related]
9. Intestinal Calcium Absorption among Hypercalciuric Patients with or without Calcium Kidney Stones.
Vezzoli G; Macrina L; Rubinacci A; Spotti D; Arcidiacono T
Clin J Am Soc Nephrol; 2016 Aug; 11(8):1450-1455. PubMed ID: 27284011
[TBL] [Abstract][Full Text] [Related]
10. Vitamin D, Hypercalciuria and Kidney Stones.
Letavernier E; Daudon M
Nutrients; 2018 Mar; 10(3):. PubMed ID: 29562593
[TBL] [Abstract][Full Text] [Related]
11. Calcium and Vitamin D Supplementation and Their Association with Kidney Stone Disease: A Narrative Review.
Bargagli M; Ferraro PM; Vittori M; Lombardi G; Gambaro G; Somani B
Nutrients; 2021 Dec; 13(12):. PubMed ID: 34959915
[TBL] [Abstract][Full Text] [Related]
12. Kidney function and influence of sunlight exposure in patients with impaired 24-hydroxylation of vitamin D due to CYP24A1 mutations.
Figueres ML; Linglart A; Bienaime F; Allain-Launay E; Roussey-Kessler G; Ryckewaert A; Kottler ML; Hourmant M
Am J Kidney Dis; 2015 Jan; 65(1):122-6. PubMed ID: 25446019
[TBL] [Abstract][Full Text] [Related]
13. The relation between bone and stone formation.
Krieger NS; Bushinsky DA
Calcif Tissue Int; 2013 Oct; 93(4):374-81. PubMed ID: 23247537
[TBL] [Abstract][Full Text] [Related]
14. Altered Calcium and Vitamin D Homeostasis in First-Time Calcium Kidney Stone-Formers.
Ketha H; Singh RJ; Grebe SK; Bergstralh EJ; Rule AD; Lieske JC; Kumar R
PLoS One; 2015; 10(9):e0137350. PubMed ID: 26332888
[TBL] [Abstract][Full Text] [Related]
15. Calcium and bone homeostasis in heterozygous carriers of CYP24A1 mutations: A cross-sectional study.
Cools M; Goemaere S; Baetens D; Raes A; Desloovere A; Kaufman JM; De Schepper J; Jans I; Vanderschueren D; Billen J; De Baere E; Fiers T; Bouillon R
Bone; 2015 Dec; 81():89-96. PubMed ID: 26117226
[TBL] [Abstract][Full Text] [Related]
16. Changes in urinary risk profile after short-term low sodium and low calcium diet in recurrent Swiss kidney stone formers.
Seeger H; Kaelin A; Ferraro PM; Weber D; Jaeger P; Ambuehl P; Robertson WG; Unwin R; Wagner CA; Mohebbi N
BMC Nephrol; 2017 Dec; 18(1):349. PubMed ID: 29202723
[TBL] [Abstract][Full Text] [Related]
17. CYP24A1 and SLC34A1 Pathogenic Variants Are Uncommon in a Canadian Cohort of Children with Hypercalcemia or Hypercalciuria.
Rousseau-Nepton I; Jones G; Schlingmann K; Kaufmann M; Zuijdwijk CS; Khatchadourian K; Gupta IR; Pacaud D; Pinsk MN; Mokashi A; Nour MA; Alexander RT; Rodd CJ
Horm Res Paediatr; 2021; 94(3-4):124-132. PubMed ID: 34320495
[TBL] [Abstract][Full Text] [Related]
18. Pediatric Age-Related Distribution of Calcium Oxalate Monohydrate and Calcium Oxalate Dihydrate in Urinary Tract Stones: Metabolic, Gender, and Ethnic Correlates.
Lotan P; Hendel H; Babaoff R; Tor R; Ben-Meir D; Morag R; Lifshitz D
J Endourol; 2023 Aug; 37(8):928-934. PubMed ID: 37265145
[No Abstract] [Full Text] [Related]
19. 1,25-(OH)2D-24 Hydroxylase (CYP24A1) Deficiency as a Cause of Nephrolithiasis.
Nesterova G; Malicdan MC; Yasuda K; Sakaki T; Vilboux T; Ciccone C; Horst R; Huang Y; Golas G; Introne W; Huizing M; Adams D; Boerkoel CF; Collins MT; Gahl WA
Clin J Am Soc Nephrol; 2013 Apr; 8(4):649-57. PubMed ID: 23293122
[TBL] [Abstract][Full Text] [Related]
20. Effects of a low-salt diet on idiopathic hypercalciuria in calcium-oxalate stone formers: a 3-mo randomized controlled trial.
Nouvenne A; Meschi T; Prati B; Guerra A; Allegri F; Vezzoli G; Soldati L; Gambaro G; Maggiore U; Borghi L
Am J Clin Nutr; 2010 Mar; 91(3):565-70. PubMed ID: 20042524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
